Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/26/2002CN1355207A Polypeptide-human regulatory transcription factor 10.89 and polynucleotide for coding it
06/26/2002CN1355206A Polypeptide-human zinc finger protein 12.76 and polynucleotide for coding it
06/26/2002CN1355205A Polypeptide-human transcription regulaton factor 11.44 and polynuceotide for coding it
06/26/2002CN1355204A Polypeptide-human amyloid glycoprotein 8.91 and polynucleotide for coding it
06/26/2002CN1355203A Polypeptide-human reverse transcription associated factor 11.88 and polynucleotide for coding it
06/26/2002CN1355202A Polypeptide-human cyclin F15.84 and polynucleotide for coding it
06/26/2002CN1355201A Polypeptide-human zinc finger protein 10.56 and polynucleotide for coding it
06/26/2002CN1355200A Polypeptide-human zinc finger protein 5128-26.4 and polynucleotide for coding it
06/26/2002CN1355199A Polypeptide-human macroprotein 0767-19.36 and polynucleotide for coding it
06/26/2002CN1355198A Polypeptide-human zinc finger protein 174-8.8 and polynucleotide for coding it
06/26/2002CN1355197A Polypeptide-human zinc finge rprotein 258-11.44 and polynucleotide for coding it
06/26/2002CN1355196A Polypeptide-Jibon ape leukovirus receptor 2-14.63 and polynucleotide for coding it
06/26/2002CN1355195A Polypeptide-growth initiation factor ING1s 10.01 and polynucleotide for coding it
06/26/2002CN1355194A Polypeptide-nuclear pore complex 10.67 and polynucleotide for coding it
06/26/2002CN1355193A Polypeptide-suprarenal leukodystrophy associated protein 10.78 and polynucleotide for coding it
06/26/2002CN1355192A Polypeptide-lipocyte differentiation associated protein 8.8 and polynucleotide for coding it
06/26/2002CN1355191A Polypeptide-glycosyl-phosphatidyl inositol polyose F12.21 and polynucleotide for coding it
06/26/2002CN1355190A Polypeptide-GTP bindin 13.86 and polynucleotide for coding it
06/26/2002CN1355189A Polypeptide-translation initiation factor eIF-2-11.44 and polynucleotide for coding it
06/26/2002CN1355188A Polypeptide-RNA bindin 14.41 and polynucleotide for coding it
06/26/2002CN1355187A Polypeptide-zinc finger protein 15.73 and polynucleotide for coding it
06/26/2002CN1355186A Polypeptide-Src2 family 9.35 and polynucleotide for coding it
06/26/2002CN1355185A Polypeptide-K ion channel 12.21 and polynucleotide for coding it
06/26/2002CN1355184A Polypeptide-transcription inhibition factor 12.54 and polynucleotide for coding it
06/26/2002CN1355183A Polypeptide-Down syndrome key area gene A9.24 and polynucleotide for coding it
06/26/2002CN1355182A Polypeptide-steroid receptor protein 11 and polynucleotide for coding it
06/26/2002CN1355181A Polypeptide-steroid thyroid hormone receptor 11.44 and polynucleotide for coding it
06/26/2002CN1355180A Polypeptide-oligophrenia protein 110.67 and polynucleotide for coding it
06/26/2002CN1355179A Polypeptide-flavoprotein subunit 8.91 and polynucleotide for coding it
06/26/2002CN1355178A Polypeptide-zinc finger protein 23 19.57 and polynucleotide for coing it
06/26/2002CN1355177A Polypeptide-zinc finger protein 14 39.13 and polynucleotide for coding it
06/26/2002CN1355176A Polypeptide-GTP bindin 9.79 and polynucleotide for coding it
06/26/2002CN1355175A Polypeptide-zinc finger protein 9.57 and polynucleotide for coding it
06/26/2002CN1355174A Polypeptide-protein carboxyl terminal bindin 11.88 and polynucleotide for coding it
06/26/2002CN1086737C Hyperthermostable protease gene
06/25/2002USRE37767 Highly stable recombinant yeasts for the production of recombinant proteins
06/25/2002USRE37766 K. lactis pyruvate-decarboxylase promoter and use thereof
06/25/2002US6410828 Nucleotide sequences for use as tools in controlling preferential gene expression in plants
06/25/2002US6410827 Nucleotide sequences coding enzymatic polypeptide for use in generating disease resistant plants
06/25/2002US6410826 Reduction of lignin biosynthesis in transgenic plants
06/25/2002US6410725 Nucleotide sequence extraction; obtain nuclelotide sequence sample, incubate with extraction solution, isolate supernatant containing extracted nucleotide sequences
06/25/2002US6410722 Nucleotide sequences associate with replication; for use as tool in genetic engineering
06/25/2002US6410721 Polynucleotide decoys that inhibit MHC-II expression and uses thereof
06/25/2002US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections
06/25/2002US6410718 Nucleotide sequences coding preferential polypeptide for use in generating disease resistant plants
06/25/2002US6410717 Nucleotide sequences coding preferential protein for use in generation of disease resistant plants
06/25/2002US6410716 Enzymatic polypeptide for use in starch processing
06/25/2002US6410711 Nucleotide sequences coding preferential polypeptide for use in human therapeutics and diagnostics
06/25/2002US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders
06/25/2002US6410708 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of inflammation, cancer and inflammatory bowel disease
06/25/2002US6410707 Forming fusion protein which includes target sequence linked to carbonic anhydrase through cleavage site and cleaving fusion protein with cleavage reagent to produce first polypeptide including target sequence
06/25/2002US6410706 Nucleic acid encoding chitin-binding receptor kinase
06/25/2002US6410705 Nucleotide sequences coding enzymatic polypeptide for use in the generation of threonine; for use in preparation of animal nutrients, human medicine and pharmacology
06/25/2002US6410704 Nucleotide sequences coding enzymatic polypeptide for use in treatment of viral disease
06/25/2002US6410702 Oligonucleotide; for use in the human therapeutics and diagnostics
06/25/2002US6410694 Naturation of a somatotropin; obtain somatotropin, incubate with detergent, recover somatotropin and remove detergent
06/25/2002US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases
06/25/2002US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies
06/25/2002US6410688 Def1
06/25/2002US6410686 Galanin receptor 2 protein
06/25/2002US6410643 Solid phase synthesis method and reagent
06/25/2002US6410531 For therapy of hepatitis c virus (hcv) infection
06/25/2002US6410518 Antisense oligonucleotide inhibition of raf gene expression
06/25/2002US6410517 Targeted gene delivery system
06/25/2002US6410516 Nuclear factors associated with transcriptional regulation
06/25/2002US6410509 Antigen; induce immunology response
06/25/2002US6410508 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
06/25/2002US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
06/25/2002US6410506 Transforming growth factor α HII
06/25/2002US6410329 Method for achieving site specific integration of exogenous DNA delivered by non-biological means to plant cells
06/25/2002US6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
06/25/2002US6410327 Isolated nucleic acid covalently linked to photolabile caging group which reversibly prevents expression of the nucleic acid; useful in gene therapy
06/25/2002US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells
06/25/2002US6410325 Antisense modulation of phospholipase A2, group VI (Ca2+-independent) expression
06/25/2002US6410324 Nucleotide sequences for use in the treatment of hyperlipidemia, atherosclerosis, hypercholesterolemia, narcolepsy and autoimmune disease
06/25/2002US6410323 Nucleotide sequences for use in the treatment of cell proliferation defects
06/25/2002US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
06/25/2002US6410321 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
06/25/2002US6410320 Kidney stem cells; for use in treatment of kidney defects
06/25/2002US6410318 Antibodies directed against binding-associated epitopes
06/25/2002US6410317 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
06/25/2002US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction
06/25/2002US6410315 Genes encoding polypeptides containing signal sequences
06/25/2002US6410314 Episomally replicating vector, its preparation and use
06/25/2002US6410313 Gene delivery system and methods of use
06/25/2002US6410311 Recombinant feline herpesvirus comprising a foreign DNA inserted into a region corresponding to a 3.0 kb EcoRI-SalI fragment of a feline herpesvirus genome
06/25/2002US6410303 Yeast culture with amplified shelf-life for use in baked goods
06/25/2002US6410302 Expression vector for the efficient generation of ethanol
06/25/2002US6410301 Genetically engineered cells; for use in generating carcinogenic agents
06/25/2002US6410300 Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
06/25/2002US6410299 Attenuated forms of bovine viral diarrhea virus
06/25/2002US6410298 Reducing frequency homologous recombination; obtain cells, transform with defective nucleotide sequences, monitor homoogous recombination in cells
06/25/2002US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines
06/25/2002US6410296 Herpes virus proteinase and method of assaying
06/25/2002US6410293 DNA fragments containing biotin biosynthetase gene and use of the same
06/25/2002US6410290 Catalases
06/25/2002US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
06/25/2002US6410288 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
06/25/2002US6410278 Process for synthesizing nucleic acid
06/25/2002US6410276 Selective amplification of target polynucleotide sequences